A revision to the United States national ALS registry’s algorithm to improve Case-Ascertainment

Paul Mehta1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USACorrespondence[email protected]
View further author information

Jaime Raymond1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Moon Han1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Reshma Punjani1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Theodore Larson1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

James D. Berry2 Sean M Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USAView further author information

Benjamin Rix Brooks3 Carolinas Medical Center, Atrium Health, University of North Carolina School of Medicine – Charlotte Campus, Charlotte, NC, USA

Björn Oskarsson4 Department of Neurology, Mayo Clinic, Jacksonville, FL, USA and

Stephen a. Goutman5 Department of Neurology, University of Michigan, Ann Arbor, MI, USAView further author information

Kevin Horton1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Your download is now in progress and you may close this window